---
title: Adragos Pharma vs Catalent
slug_a: adragos-pharma
slug_b: catalent
site: cdmo
review_signal_gate: closed
canonical_path: /compare/adragos-pharma/catalent
generated_by: BioBM Editorial AI
---

# Adragos Pharma vs Catalent

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Adragos Pharma (adragos-pharma) is listed for cdmo. Global CDMO headquartered in Munich offering end-to-end development and manufacturing for small molecules and biologics, including sterile/non-sterile liquids, solids, semi-solids, lyophilization, and prefilled syringes across seven facilities in Europe and Japan.

Services: 17. Modalities: 2. Indications: 1. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (17).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Catalent (catalent) is listed for cdmo. Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.

Services: 32. Modalities: 6. Indications: 0. Locations: 12. Certifications: 3. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (32).

Review summary: Review summary withheld until site-level review gate opens.